RecruitingNot ApplicableNCT04672551

EMDR Treatment in PTSD Following Cardiac Events


Sponsor

University of Zurich

Enrollment

60 participants

Start Date

Nov 21, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

Cardiac events can often result in debilitating and persistent psychological symptoms. A key question involves whether optimal treatment of cardiac-induced posttraumatic stress disorder (PTSD) reduces PTSD symptoms and thereby may offset the risk of recurrent or worsening cardiovascular disease. Cardiac-induced PTSD 1) is prevalent, 2) features symptoms unique to internal ongoing somatic threat, with fears and worries that can be distinguished from PTSD resulting from external causes, 3) is persistent, 4) is associated with negative physical and emotional consequences, and 5) has not been the subject of randomized-controlled treatment trials (RCT). There is preliminary evidence suggesting that patients with cardiac-disease induced PTSD might particularly profit from EMDR. Nevertheless, this possibility has not been tested in cardiac-induced PTSD. Currently, patients with cardiac-induced PTSD are not routinely offered trauma-focused therapies, with a lack of scientific evidence likely being one major reason for this omission. If our proposed RCT shows that EMDR can be an effective treatment for patients with ACS-induced PTSD, EMDR could be routinely implemented as first-line treatment. The RCT outcomes might inform larger trials to test whether poor prognosis in terms of major adverse cardiovascular events can be improved through EMDR in patients with cardiac-induced PTSD.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Plain Language Summary

Simplified for easier understanding

This study is testing a psychological therapy called EMDR (Eye Movement Desensitization and Reprocessing) for people who developed PTSD (post-traumatic stress disorder) after experiencing a heart attack or other major cardiac event. EMDR is a well-established trauma therapy, and this study wants to see how well it works specifically for cardiac-related trauma. **You may be eligible if you:** - Are between 18 and 70 years old - Have experienced a heart attack (STEMI or non-STEMI) that has been confirmed by a cardiologist - Have been diagnosed with PTSD that was caused by your cardiac event **You may NOT be eligible if you:** - Have a psychotic disorder, bipolar disorder, or substance abuse problem - Have active thoughts of suicide - Are currently taking non-selective beta blockers (like propranolol) - Are currently receiving other psychological or psychiatric treatment outside of this trial - Have significant vision problems (such as a strong squint) that would prevent participation in EMDR Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALEMDR Treatment

Eight individual EMDR sessions lasting for 1 hours will be provided over 8 weeks by licensed EMDR therapists from the German-speaking part of Switzerland. Each EMDR session follows a standardized 8-phase protocol.


Locations(1)

University Hospital Zurich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04672551


Related Trials